Autobio Diagnostics Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.049x

Autobio Diagnostics Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Autobio Diagnostics Co Ltd (603658) has a cash flow conversion efficiency ratio of 0.049x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥435.24 Million ≈ $63.69 Million USD) by net assets (CN¥8.85 Billion ≈ $1.29 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Autobio Diagnostics Co Ltd (2011–2025)

Cash flow conversion efficiency of Autobio Diagnostics Co Ltd from 2011 to 2025. This chart illustrates how Autobio Diagnostics Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 603658 stock price and chart for real-time trading data and today's change.

Autobio Diagnostics Co Ltd Cash Flow Conversion Ratio Explained

Autobio Diagnostics Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Autobio Diagnostics Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Autobio Diagnostics Co Ltd ranked by their cash flow conversion efficiency. Also see 603658 market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
M/I Homes Inc NYSE:MHO	0.011x
Inner Mongolia Yuan Xing Energy Co Ltd SHE:000683	0.104x
Mangalore Refinery and Petrochemicals Limited NSE:MRPL	0.305x
First Interstate BancSystem Inc NASDAQ:FIBK	0.017x
Avista Corporation NYSE:AVA	0.064x
Downer Edi Ltd AU:DOW	0.105x
Amedisys Inc NASDAQ:AMED	0.053x
Exponent Inc NASDAQ:EXPO	0.107x

Annual Cash Flow Conversion Efficiency for Autobio Diagnostics Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Autobio Diagnostics Co Ltd from 2011 to 2025. Review Autobio Diagnostics Co Ltd (603658) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥9.02 Billion ≈ $1.32 Billion	CN¥1.34 Billion ≈ $196.33 Million	0.149x	-1.21%
2024-12-31	CN¥8.69 Billion ≈ $1.27 Billion	CN¥1.31 Billion ≈ $191.59 Million	0.151x	-11.19%
2023-12-31	CN¥8.67 Billion ≈ $1.27 Billion	CN¥1.47 Billion ≈ $215.09 Million	0.170x	-13.89%
2022-12-31	CN¥7.91 Billion ≈ $1.16 Billion	CN¥1.56 Billion ≈ $228.05 Million	0.197x	-0.21%
2021-12-31	CN¥7.40 Billion ≈ $1.08 Billion	CN¥1.46 Billion ≈ $213.82 Million	0.197x	+30.67%
2020-12-31	CN¥6.59 Billion ≈ $963.64 Million	CN¥994.71 Million ≈ $145.56 Million	0.151x	-52.79%
2019-12-31	CN¥2.63 Billion ≈ $385.52 Million	CN¥842.89 Million ≈ $123.34 Million	0.320x	-3.79%
2018-12-31	CN¥1.97 Billion ≈ $287.67 Million	CN¥653.73 Million ≈ $95.66 Million	0.333x	+16.62%
2017-12-31	CN¥1.69 Billion ≈ $247.22 Million	CN¥481.73 Million ≈ $70.49 Million	0.285x	+12.80%
2016-12-31	CN¥1.64 Billion ≈ $240.70 Million	CN¥415.82 Million ≈ $60.85 Million	0.253x	-41.15%
2015-12-31	CN¥718.55 Million ≈ $105.15 Million	CN¥308.63 Million ≈ $45.16 Million	0.430x	-16.26%
2014-12-31	CN¥500.94 Million ≈ $73.30 Million	CN¥256.93 Million ≈ $37.60 Million	0.513x	+69.15%
2013-12-31	CN¥340.42 Million ≈ $49.81 Million	CN¥103.22 Million ≈ $15.10 Million	0.303x	+2.28%
2012-12-31	CN¥233.84 Million ≈ $34.22 Million	CN¥69.32 Million ≈ $10.14 Million	0.296x	-8.02%
2011-12-31	CN¥156.96 Million ≈ $22.97 Million	CN¥50.59 Million ≈ $7.40 Million	0.322x	--

About Autobio Diagnostics Co Ltd

SHG:603658 China Medical Devices

Market Cap

$3.32 Billion

CN¥22.72 Billion CNY

Market Cap Rank

#4483 Global

#671 in China

Share Price

CN¥39.76

Change (1 day)

-0.58%

52-Week Range

CN¥28.72 - CN¥39.99

All Time High

CN¥131.73